{
    "clinical_study": {
        "@rank": "50182", 
        "arm_group": [
            {
                "arm_group_label": "SUPREP Bowel Prep Kit", 
                "arm_group_type": "Experimental", 
                "description": "SUPREP Bowel Prep Kit"
            }, 
            {
                "arm_group_label": "FDA approved bowel preparation", 
                "arm_group_type": "Active Comparator", 
                "description": "FDA approved bowel preparation containing electrolytes"
            }
        ], 
        "brief_summary": {
            "textblock": "To compare the safety, tolerance and efficacy of SUPREP Bowel Prep Kit to an FDA approved\n      control as bowel preparations prior to colonoscopy in adult patients."
        }, 
        "brief_title": "BLI800-480: A Safety and Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects", 
        "condition": [
            "Colonoscopy", 
            "Bowel Preparation", 
            "Endoscopy"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Male or female outpatients who are undergoing colonoscopy for a routinely accepted\n        indication.\n\n        At least 18 years of age\n\n        If female, and of child-bearing potential, is using an acceptable form of birth control\n\n        Negative urine pregnancy test at screening, if applicable\n\n        In the Investigator's judgment, subject is mentally competent to provide informed consent\n        to participate in the study\n\n        Exclusion Criteria:\n\n        Subjects with known or suspected ileus, severe ulcerative colitis, gastrointestinal\n        obstruction, gastric retention, bowel perforation, toxic colitis or megacolon.\n\n        Subjects who had previous significant gastrointestinal surgeries\n\n        Subjects with uncontrolled pre-existing electrolyte abnormalities, or those with\n        clinically significant electrolyte abnormalities based on screening laboratory results,\n        such as hypernatremia, hyponatremia, hyperphosphatemia, hypokalemia, hypocalcemia,\n        dehydration, or those secondary to the use of diuretics or angiotensin converting enzyme\n        (ACE) inhibitors.\n\n        Subjects with a prior history of renal, liver or cardiac insufficiency\n\n        Subjects with impaired consciousness that predisposes them to pulmonary aspiration.\n\n        Subjects undergoing colonoscopy for foreign body removal and/or decompression.\n\n        Subjects who are pregnant or lactating, or intending to become pregnant during the study.\n\n        Subjects of childbearing potential who refuse a pregnancy test.\n\n        Subjects allergic to any preparation components.\n\n        Subjects who, in the opinion of the Investigator, should not be included in the study for\n        any reason, including inability to follow study procedures.\n\n        Subjects who have participated in an investigational surgical, drug, or device study\n        within the past 30 days.\n\n        Subjects who withdraw consent before completion of Visit 1 procedures."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "320", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01786629", 
            "org_study_id": "BLI800-480"
        }, 
        "intervention": [
            {
                "arm_group_label": "SUPREP Bowel Prep Kit", 
                "description": "solution for oral administration prior to colonoscopy", 
                "intervention_name": "SUPREP Bowel Prep Kit", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "FDA approved bowel preparation", 
                "description": "solution for oral administration prior to colonoscopy", 
                "intervention_name": "FDA approved bowel preparation containing electrolytes", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Magnesium Sulfate", 
                "Sodium sulfate"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 2, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Mobile", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "36693"
                    }, 
                    "name": "University of South Alabama"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Anaheim", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92801"
                    }, 
                    "name": "Anaheim Clinical Trials"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46202"
                    }, 
                    "name": "Indiana University Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brockton", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02302"
                    }, 
                    "name": "Commonwealth Clinical Studies"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jackson", 
                        "country": "United States", 
                        "state": "Mississippi", 
                        "zip": "39202"
                    }, 
                    "name": "Gastrointestinal Associates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Great Neck", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11023"
                    }, 
                    "name": "Long Island GI Research Group"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Raleigh", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27612"
                    }, 
                    "name": "Wake Research Associates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97210"
                    }, 
                    "name": "Northwest Gastroenterology Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Franklin", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37067"
                    }, 
                    "name": "Franklin Gastroenterology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlottesville", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "22911"
                    }, 
                    "name": "Charlottesville Medical Research"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "BLI800-480: A Safety and Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects", 
        "overall_official": {
            "affiliation": "Braintree Laboratories, Inc.", 
            "last_name": "John McGowan, MPH", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "% of subjects with successful preparation rated by blinded colonoscopist on a 4 point scale (1= poor to 4 = excellent)", 
            "safety_issue": "No", 
            "time_frame": "1 Day of colonoscopy"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01786629"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Frequency of adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "Less than 30 days"
        }, 
        "source": "Braintree Laboratories", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Braintree Laboratories", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}